Geriatric Medicine Doctors in Farmington Hills, MI Accepting Medicare

2 Geriatric Medicine doctors found. Showing 1 - 2

Annette Carron, DO Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 28080 Grand River Ave, Suite 306, Farmington Hills, MI 48336 Phone: 734-464-0887    Fax: 734-402-0254

Dr. Anhkiet L Tran, M.D. Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 29736 Orion Ct, Farmington Hills, MI 48334 Phone: 248-229-4170

News Archive

Aggressive breast cancer's metastasis molecular switch identified

Scientists at Weill Cornell Medical College have discovered the molecular switch that allows aggressive triple negative breast cancer cells to grow the amoeba-like protrusions they need to crawl away from a primary tumor and metastasize throughout the body. Their findings, published in Cancer Cell, suggest a novel approach for developing agents to treat cancer once it has spread.

Study reports that less-invasive option for spinal stenosis poses 'trade-off' in outcomes

Interspinous spacer implantation-a less-invasive alternative surgical option for spinal stenosis-has a lower complication rate than spinal fusion, reports a study in the May 1 issue of Spine The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Florida weighs next steps for small business insurance exchange; N.J. considers COBRA eligibility expansion; Other highlights

When Republican lawmakers created the Florida Health Choices program in 2008, they billed it as a way to deregulate the health-care market for small businesses. Two years later, Florida Health Choices has still not started offering coverage, and its leaders and lawmakers face a philosophical choice that could determine whether the program survives.

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.

Read more Medical News

› Verified 3 days ago